Predictors of response after intravitreal bevacizumab injection for neovascular age-related macular degeneration

被引：0
|
作者：
Yeo Jue Byun
Sung Jun Lee
Hyoung Jun Koh
机构：
[1] Yonsei University College of Medicine,Institute of Vision Research, Department of Ophthalmology
[2] Dongguk University School of Medicine,Department of Ophthalmology, Dongguk University Ilsan Hospital
[3] Yonsei University College of Medicine,Department of Ophthalmology
来源：
Japanese Journal of Ophthalmology | 2010年 / 54卷
关键词：
AMD; bevacizumab; nonresponders; OCT; responders;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：571 / 577
页数：6
相关论文
共 50 条
  • [21] Bevacizumab for Neovascular Age-Related Macular Degeneration
    Silva, Aline
    Furlan, Luiz
    Elias, Flavia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 75 - 76
  • [22] Visual hallucinations after intravitreal injection of ranibizumab in neovascular age-related macular degeneration
    C S H Tan
    Eye, 2011, 25 : 1374 - 1374
  • [23] Comment on "Intravitreal conbercept injection for neovascular age-related macular degeneration"
    Calugaru, Dan
    Calugaru, Mihai
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2020, 13 (02) : 362 - 363
  • [24] Comment on “Intravitreal conbercept injection for neovascular age-related macular degeneration”
    Dan C?lug?ru
    Mihai C?lug?ru
    International Journal of Ophthalmology, 2020, (02) : 362 - 364
  • [25] Visual Results Following Intravitreal Bevacizumab in Neovascular Age-Related Macular Degeneration
    Iqbal, Kashif
    Baig, Jamil
    Jamil, Ahmad Zeeshan
    Jamil, Hannan
    Mirza, Khurram
    Khan, Tariq
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2011, 21 (09): : 535 - 538
  • [26] Intravitreal bevacizumab therapy for neovascular age-related macular degeneration:: a pilot study
    Abraham-Marin, Maura Lucy
    Cortes-Luna, Carlos Fernando
    Alvarez-Rivera, Griselda
    Hernandez-Rojas, Myriam
    Quiroz-Mercado, Hugo
    Morales-Canton, Virgilio
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2007, 245 (05) : 651 - 655
  • [27] Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration
    Markus S. Ladewig
    Stefanie E. Karl
    Victoria Hamelmann
    Hans-Martin Helb
    Hendrik P. N. Scholl
    Frank G. Holz
    Nicole Eter
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2008, 246 : 17 - 25
  • [28] Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration
    Ladewig, Markus S.
    Karl, Stefanie E.
    Hamelmann, Victoria
    Helb, Hans-Martin
    Scholl, Hendrik P. N.
    Holz, Frank G.
    Eter, Nicole
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2008, 246 (01) : 17 - 25
  • [29] Intravitreal bevacizumab treatment for neovascular age-related macular degeneration and thromboembolic events
    Weinstein, Orly
    Abu Tailakh, Muhammad
    Lifshitz, Tova
    Novack, Victor
    Levy, Jaime
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2020, 30 (01) : 66 - 71
  • [30] Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study
    Maura Lucy Abrahám-Marin
    Carlos Fernando Cortés-Luna
    Griselda Álvarez-Rivera
    Myriam Hernández-Rojas
    Hugo Quiroz-Mercado
    Virgilio Morales-Cantón
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2007, 245 : 651 - 655
12345